A high FIB-4 score may be an early sign of severe liver damage in patients with primary antibody deficiencies
Turkish Journal of Medical Sciences · 16.06.2026 · 56 (3) · 847-859
DOI: 10.55730/1300-0144.6219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 16.06.2026. Verfasst von Hacı Uğur Muşabak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Allergy, Baskent University, Faculty of Medicine, Ankara, Turkiye. Hauptthemen laut MEDLINE: Liver Cirrhosis, Common Variable Immunodeficiency. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: Liver damage is a significant complication that increases mortality and morbidity in primary immunodeficiencies (PIDs). Although biopsy is the gold standard, the fibrosis-4 (FIB-4) scoring system is a noninvasive method for diagnosing liver fibrosis. In this study, we investigated the value of the FIB-4 score as an early indicator of liver damage in patients with primary antibody deficiencies (PADs). Materials and methods: Of 52 patients, 40 had common variable immunodeficiency (CVID), 12 had immunoglobulin G subclass deficiency (IgG-SGD), and they were enrolled in the study. Patients were divided into hematology, rheumatology + dermatology, gastroenterology/hepatology, and respiratory diseases groups based on their clinical phenotypes. FIB-4 score calculation and transient elastography were used to detect liver complications.
Results
FIB-4 scores were significantly higher in CVID patients than in those with SGD (p = 0.003), and were also elevated in PAD patients with hematology and gastroenterology/hepatology phenotypes compared with rheumatology + dermatology and respiratory phenotypes (p < 0.001). In the gastroenterology/hepatology group patients, FIB-4 scores showed a strong positive correlation with elastography values (r = 0.825, p < 0.001). FIB-4 and elastography showed moderate to good agreement (κ = 0.41–0.60) for detecting significant fibrosis, and FIB-4 was also a valuable indicator in high-risk patients (≥3.25).
Conclusions
This study is the first to show that FIB-4 may serve as a practical and noninvasive indicator of liver damage in PADs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Immunology and Allergy, Baskent University, Faculty of Medicine, Ankara, Turkiye.
- Department of Immunology-Allergy, Etlik City Hospital, Ankara, Turkiye.
ORCID-Profile: Hacı Uğur Muşabak, Tuba Erdoğan, Emre Özbek, Dudu Merve Durak Anşin, Zumrud Mehti
Zitieren
APA
Muşabak, H. U., Erdoğan, T., Özbek, E., Durak Anşin, D. M., & Mehti, Z. (2026). A high FIB-4 score may be an early sign of severe liver damage in patients with primary antibody deficiencies. Turkish Journal of Medical Sciences, 56(3), 847-859. https://doi.org/10.55730/1300-0144.6219
Vancouver
Muşabak HU, Erdoğan T, Özbek E, Durak Anşin DM, Mehti Z. A high FIB-4 score may be an early sign of severe liver damage in patients with primary antibody deficiencies. Turkish Journal of Medical Sciences. 2026;56(3):847-859. doi:10.55730/1300-0144.6219
BibTeX
@article{Muabak2026,
author = {Muşabak, Hacı Uğur and Erdoğan, Tuba and Özbek, Emre and Durak Anşin, Dudu Merve and Mehti, Zumrud},
title = {A high FIB-4 score may be an early sign of severe liver damage in patients with primary antibody deficiencies},
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {3},
pages = {847--859},
doi = {10.55730/1300-0144.6219}
}
EUVIMED